We are live on
!
Find out more
Denali Therapeutics
DNLI
DNLI
118 hedge funds and large institutions have $1.09B invested in Denali Therapeutics in 2019 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 38 increasing their positions, 25 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
52% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 25
29% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 14
4% more funds holding
Funds holding: 114 → 118 (+4)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0.38% less ownership
Funds ownership: 74.94% → 74.56% (-0.38%)
26% less capital invested
Capital invested by funds: $1.49B → $1.09B (-$391M)
50% less call options, than puts
Call options by funds: $871K | Put options by funds: $1.75M
Holders
118
Holders Change
+4
Holders Change %
+3.51%
% of All Funds
2.59%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
18
Increased
38
Reduced
25
Closed
14
Calls
$871K
Puts
$1.75M
Net Calls
-$883K
Net Calls Change
-$1.61M
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.47M |
| 2 |
CC
Casdin Capital
New York
|
+$4.78M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$3.7M |
| 4 |
Bank of New York Mellon
New York
|
+$2.14M |
| 5 |
Millennium Management
New York
|
+$1.94M |
Top Sellers
| 1 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$11M |
| 2 |
State Street
Boston,
Massachusetts
|
-$7.53M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.63M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$2.5M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$2.15M |
